A series of CC chemokine receptor-4 (CCR4) antagonists were examined in a previous report in an attempt to improve metabolic stability in human liver microsomes. In this study, the cycloheptylamine moiety of N-cycloheptyl-6, 7-dimethoxy-2-(4-pyrrolidin-1-ylpiperidin-1- yl) quinazolin-4-amine 1 was replaced with the p-chloroaniline moiety, and the resulting compound, N-(4-chlorophenyl)-6, 7-dimethoxy-2-(4-pyrrolidin-1-ylpiperidin-1-yl) ...